0.00Open4.51Pre Close0 Volume0 Open Interest73.00Strike Price0.00Turnover1890.94%IV-2.82%PremiumDec 27, 2024Expiry Date6.76Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9741Delta0.0151Gamma17.69Leverage Ratio-44.3675Theta0.0000Rho17.23Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet